OIG Work Plan Monthly Review: January 2018

Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
Jan 30, 2018  
placeholder  ENFORCEMENT
OIG Work Plan Monthly Review: January 2018
From - G2 Compliance Advisor
Opioid drug-related issues continue to command the lion's share of OIG Work Plan attention, including two of this month's six new items…
Read More

placeholder  INDUSTRY BUZZ
Genetic Profiling: Study Casts Doubt on Cost-Effectiveness of Leading Breast Cancer Recurrence Assay
From - Laboratory Industry Report
Among the many genetic profiling assays entering the commercial market, few have been more successful than Genomic Heath's Oncotype DX, which is now covered by most of …
Read More
     


placeholder  TESTING TRENDS
Older Adults Undertested, Underdiagnosed with the Flu
From - Diagnostic Testing & Emerging Technologies
Hospitals around the nation are seeing high volumes of patients with the flu this season. A new study, published online Jan. 17 in the Journal of the American Geriatrics Society, shows that…
Read More

placeholder  TECHNOLOGY
Innovation: AMP Issues New Guidelines for NGS Pipeline Validation
From - National Intelligence Report
Molecular next-generation sequencing (NGS) tests have spurred tremendous growth in the lab industry. But as often happens with innovation, NGS technology may be…
Read More

 


For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2018, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320